Overview

  • Product nameLP-44
  • Description
    Highly potent, selective 5-HT7 agonist
  • Biological descriptionHighly potent, selective 5-HT7 agonist (Ki = 0.22 nM). Shows >200 and >1000-fold selectivity over 5-HT1A and 5-HT2A receptors, respectively. Supresses REM sleep.
  • Purity> 99%

Properties

    References for LP-44 (ab120593)

    This product has been referenced in:
    • Leopoldo M  et al. Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders. Pharmacol Ther 129:120-48 (2011). Read more (PubMed: 20923682) »
    • Monti JM  et al. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat. Behav Brain Res 191:184-9 (2008). Read more (PubMed: 18466985) »
    • Leopoldo M  et al. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents. J Med Chem 47:6616-24 (2004). Read more (PubMed: 15588097) »

    See 0 Publications for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120593.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"